CN Patent

CN117186150B — 一种lfa-1抑制剂的制备方法

Assigned to Vivavision Biopharma Shanghai Co ltd · Expires 2026-04-17 · 0y expired

What this patent protects

本申请提供了一种LFA‑1抑制剂的制备方法，具体为一种式(IX)所示化合物或其盐及其用途、眼科组合物，式(IX)所示化合物或其盐可用作LFA‑1抑制剂，能够治疗眼科疾病，例如干眼综合征。

USPTO Abstract

本申请提供了一种LFA‑1抑制剂的制备方法，具体为一种式(IX)所示化合物或其盐及其用途、眼科组合物，式(IX)所示化合物或其盐可用作LFA‑1抑制剂，能够治疗眼科疾病，例如干眼综合征。

Drugs covered by this patent

Patent Metadata

Patent number
CN117186150B
Jurisdiction
CN
Classification
—
Expires
2026-04-17
Drug substance claim
No
Drug product claim
No
Assignee
Vivavision Biopharma Shanghai Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.